These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36868122)

  • 1. The Impact of MOMENTUM 3 Trial Eligibility on Left Ventricular Assist Device Outcomes: A Real-World Experience.
    George TJ; Kabra N; DiMaio JM; Rawitscher DA; Afzal A
    J Surg Res; 2023 Jul; 287():40-46. PubMed ID: 36868122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Mortality Among Durable Left Ventricular Assist Device Recipients Ineligible for Clinical Trials.
    Brescia AA; Watt TMF; Pagani FD; Cascino TM; Zhang M; McCullough JS; Shore S; Likosky DS; Aaronson KD; Thompson MP;
    JAMA Netw Open; 2021 Jan; 4(1):e2032865. PubMed ID: 33416886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalizability of Trial Data to Real-World Practice: An Analysis of The Society of Thoracic Surgeons Intermacs Database.
    Brescia AA; Watt TMF; Pagani FD; Cascino TM; Zhang M; McCullough JS; Shore S; Likosky DS; Aaronson KD; Cantor RS; Deng L; Kirklin JK; Thompson MP
    Ann Thorac Surg; 2022 Oct; 114(4):1307-1317. PubMed ID: 34619136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
    Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N
    JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter evaluation of the HeartMate 3 risk score.
    Grewal J; Tripathi N; Bortner B; Gregoski MJ; Cook D; Britt A; Hajj J; Rofael M; Sheidu M; Montovano MJ; Mehta M; Hajduczok AG; Rajapreyar IN; Brailovsky Y; Genuardi MV; Kanwar MK; Atluri P; Lander M; Shah P; Hsu S; Kilic A; Houston BA; Mehra MR; Sheikh FH; Tedford RJ
    J Heart Lung Transplant; 2024 Apr; 43(4):626-632. PubMed ID: 38061468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
    Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
    JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.
    Mehra MR; Cleveland JC; Uriel N; Cowger JA; Hall S; Horstmanshof D; Naka Y; Salerno CT; Chuang J; Williams C; Goldstein DJ;
    Eur J Heart Fail; 2021 Aug; 23(8):1392-1400. PubMed ID: 33932272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Bleeding Revision on Outcomes After Left Ventricular Assist Device Implantation.
    Angleitner P; Simon P; Kaider A; Wiedemann D; Dimitrov K; Schlöglhofer T; Rajek MA; Riebandt J; Laufer G; Zimpfer D
    Ann Thorac Surg; 2019 Aug; 108(2):517-523. PubMed ID: 30851258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of right ventricular assist device implantation following left ventricular assist device implantation: Systematic review and meta-analysis.
    Reid G; Mork C; Gahl B; Appenzeller-Herzog C; von Segesser LK; Eckstein F; Berdajs DA
    Perfusion; 2022 Nov; 37(8):773-784. PubMed ID: 34112048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redo sternotomy versus left ventricular assist device explant as risk factors for early mortality following heart transplantation.
    Ribeiro RVP; Alvarez JS; Fukunaga N; Yu F; Adamson MB; Foroutan F; Cusimano RJ; Yau T; Ross H; Alba AC; Billia F; Badiwala MV; Rao V
    Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):603-610. PubMed ID: 33137824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing Right Ventricular Failure After Left Ventricular Assist Device Implant at a Destination Therapy Center.
    George TJ; Sheasby J; Milligan G; Kabra N; Dimaio JM; Rawitscher DA; Afzal A
    Am J Cardiol; 2023 Aug; 201():1-7. PubMed ID: 37348151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cardiac arrest with aortic cross-clamping during left ventricular assist device implantation.
    Kawabori M; Kurihara C; Critsinelis A; Chou BP; Zhang Q; Kaku Y; Civitello AB; Morgan JA
    Interact Cardiovasc Thorac Surg; 2020 Jan; 30(1):47-53. PubMed ID: 31535130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex disparities in left ventricular assist device implantation outcomes: A systematic review and meta-analysis of over 50 000 patients.
    Arjomandi Rad A; Kapadia S; Zubarevich A; Nanchahal S; Van den Eynde J; Vardanyan R; Bareka M; Krasopoulos G; Quarto C; Ruhparwar A; Athanasiou T; Weymann A
    Artif Organs; 2023 Feb; 47(2):273-289. PubMed ID: 36461903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elderly Patients With Higher Acuity Have Similar Left Ventricular Assist Device Outcomes as Younger Patients at a Nontransplant Center.
    George TJ; Kabra N; DiMaio JM; Rawitscher DA; Afzal A
    Am J Cardiol; 2023 Feb; 189():93-97. PubMed ID: 36521414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure.
    Mezzacappa C; Ravindra NG; Caraballo C; Chouairi F; Miller PE; Clarke JD; Gruen J; Mori M; McCullough M; Mullan C; Geirsson A; Rogers JG; Anwer M; Desai N; Ahmad T
    PLoS One; 2020; 15(12):e0242928. PubMed ID: 33270648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial.
    Sheikh FH; Ravichandran AK; Goldstein DJ; Agarwal R; Ransom J; Bansal A; Kim G; Cleveland JC; Uriel N; Sheridan BC; Chomsky D; Patel SR; Dirckx N; Franke A; Mehra MR
    Circ Heart Fail; 2021 Oct; 14(10):e008360. PubMed ID: 34525837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.